Joshua P. Lewis; Nicholette D. Palmer; Pamela J. Hicks; Michele M. Sale; Carl D. Langefeld; Barry I. Freedman; Jasmin Divers; Donald W. Bowden Even though all of the SNPs examined in this study showed ...
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback